2. Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults “Clinicians should consider whether it is appropriate to prescribe IR methylphenidate, given its limited efficacy and increased risk of harms.” https://t.c
@dejohanpauwels @TomRBeckers @bazart_band @nataliamusic @bbrevelation @VTMTheVoice Ik raad u toch aan dit overzicht met de nodige scepsis te benaderen; de "Financial disclosures" hier spreken boekdelen, evenals het ontbreken van meta-analyses van de meest
Is this methodologically sound, high-quality meticulous Cochrane's reciew and meta-analysis a nail in the coffin of methylphenidate effects and safety in adults https://t.co/QKTdr5Wxt3
Metilfenidato IR en pacientes con TDAH en adulto https://t.co/KHuiiO6pqb
成人における注意欠陥多動性障害（ADHD）に対するIRメチルフェニデートの効能・効果 https://t.co/L6X5AP4JCB
M-A: IR methylphenidate may reduce symptoms of ADHD in adults with investigator‐rated scales (MD= −20.70; −23.97 to −17.43) and with participant‐rated scales (SMD= −0.59; −1.25 to 0.06; I2 = 69%) in comparison with placebo (low certainty evidence) https://
RT @CochraneUK: This new @CochraneLibrary review on immediate release #methylphenidate for attention deficit hyperactivity disorder #ADHD i…
This new @CochraneLibrary review on immediate release #methylphenidate for attention deficit hyperactivity disorder #ADHD in adults looks at evidence from 10 trials involving 497 adults. Read more here: https://t.co/CY13j7OuV8 https://t.co/XJjKneN3HH https
RT @Wiley_Nursing: This new @CochraneLibrary review on immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD…
This new @CochraneLibrary review on immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD in adults looks at evidence from 10 trails involving 497 adults. Read more here: https://t.co/r1D1JidLtm https://t.co/S4J2ljFPea
This new @CochraneLibrary review on immediate‐release #methylphenidate for attention deficit hyperactivity disorder #ADHD in adults looks at evidence from 10 trials involving 497 adults. Read more here: https://t.co/OmzyGs0QSm https://t.co/RoH8tmw1Ub
『成人における注意欠陥多動性障害（ADHD）に対するIRメチルフェニデートの効能・効果』 https://t.co/ajM7Oca7sd #メチルフェニデート #ADHD #注意欠如多動症
RT @CochraneJapan: 成人における注意欠陥多動性障害（ADHD）に対するIRメチルフェニデートの効能・効果 https://t.co/iy5uRfQKea
RT @CochraneJapan: 成人における注意欠陥多動性障害（ADHD）に対するIRメチルフェニデートの効能・効果 https://t.co/iy5uRfQKea
成人における注意欠陥多動性障害（ADHD）に対するIRメチルフェニデートの効能・効果 https://t.co/iy5uRfQKea
RT @CochraneUK: Immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD in adults https://t.co/B43R9StaqO New…
Immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD in adults https://t.co/B43R9StaqO New @CochraneDPLP systematic review looks at the evidence from 10 trials involving 497 adults. https://t.co/xa91DBWFJw
RT @CochraneLibrary: Immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD in adults https://t.co/ejSpRZnvnL…
Immediate‐release methylphenidate for attention deficit hyperactivity disorder #ADHD in adults https://t.co/ejSpRZnvnL New @CochraneDPLP systematic review looks at the evidence from 10 trails involving 497 adults.
RT @CochraneDPLP: New review published on 'Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults'…
RT @CochraneDPLP: New review published on 'Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults'…
RT @CochraneDPLP: New review published on 'Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults'…
RT @CochraneDPLP: New review published on 'Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults'…
New article: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. https://t.co/mTkgkFUNow #MDS #mdssm #hematology https://t.co/XOIkwyWKKb